Package 59651-524-01

{"route": ["ORAL"], "spl_id": "0fda7521-a452-4bac-953d-7d464d75ca22", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["0fda7521-a452-4bac-953d-7d464d75ca22"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (59651-524-01)", "package_ndc": "59651-524-01", "marketing_start_date": "20230914"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "59651-524_0fda7521-a452-4bac-953d-7d464d75ca22", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "59651-524", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA216419", "marketing_category": "ANDA", "marketing_start_date": "20230914", "listing_expiration_date": "20261231"}